lisuride, terguride and derivatives thereof for use in prophylaxis and / or therapy of fibrotic disorders

• 收藏
• 分享

专利权人:

SINOXA PHARMA UG

发明人:

HEINZ PALLA,JOHANNES TACK,REINHARD HOROWSKI

申请号：

BR112013011640

公开号：

BR112013011640A2

申请日:

2011.11.04

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

The present invention relates to the use of 5-HT2 receptor antagonists and in particular of 8-alpha-ergolines such as lisuride, terguride and the derivatives thereof as 5-HT2B and 5-HT2A receptor antagonists and antioxidants in preferably higher-dosed and preferably continuous use for the treatment, progression prophylaxis and general prophylaxis of organ fibroses and other pathological organ remodeling caused by mesenchymal proliferation

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/